John Yudkin, emeritus professor of medicine at University College in London, conducted a second study where he found that Novo Nordisk “used trade agreements in South Africa to block the government’s use of generic antiretroviral drugs” and in 2010 “Novo Nordisk invoked negative headlines by threatening to withdraw all its products from Greece because of a governmental order to cut all drug prices by 25%.”